Latest Close
$11.82
News
ABCL
AbCellera Biologics Inc. News
This news view pulls recent coverage and headlines tied to ABCL.
1y Change
$6.16 (+108.83%)
Market Cap
$3.83B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
AbCellera to Present at Upcoming Investor Conferences in November 2026
Business Wire • Oct 22, 2026
Read articleNurix Therapeutics, Inc. (NRIX) Q3 Earnings and Revenues Surpass Estimates
Zacks • Oct 12, 2026
Read articleAbCellera Biologics' ABCL635 Seen With Best-in-Class Potential in Menopause, UBS Says
MT Newswires • Oct 12, 2026
Read articleUBS Initiates AbCellera Biologics at Buy With $18 Price Target
MT Newswires • Oct 12, 2026
Read articleAbCellera Biologics (ABCL) Could Be 27% Undervalued As ABCL635 Data Draws Focus
Simply Wall St. • Oct 9, 2026
Read articleAbCellera to Present Phase 1/2 ABCL635 Data at Menopause Society Meeting
MT Newswires • Oct 9, 2026
Read article